Treatment of Polyangiitis
common.study.values.description
“Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)”
The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with GPA and MPA compared with placebo.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - IFX-1
Single IV infusions of IFX-1
Drug - IFX-1
Single IV infusions of IFX-1
Drug - Placebo
Placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase II Efficacy and Safety Study of IFX-1 in Add-On to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
common.study.values.clinical-trial-id
NCT03712345
participant.views.study.view.id
ejRnRe
